应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
02162 康诺亚-B
休市中 08-23 16:08:27
32.400
-0.700
-2.11%
最高
32.950
最低
32.050
成交量
23.70万
今开
32.450
昨收
33.100
日振幅
2.72%
总市值
90.63亿
流通市值
90.63亿
总股本
2.80亿
成交额
766.73万
换手率
0.08%
流通股本
2.80亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
康诺亚-B08月21日遭主力抛售105万元 环比增加288.89%
自选股智能写手 · 08-21
康诺亚-B08月21日遭主力抛售105万元 环比增加288.89%
康诺亚-B08月20日主力资金流出27万元 连续3日减仓
自选股智能写手 · 08-20
康诺亚-B08月20日主力资金流出27万元 连续3日减仓
康诺亚-B08月19日遭主力抛售212万元 环比增加351.06%
自选股智能写手 · 08-19
康诺亚-B08月19日遭主力抛售212万元 环比增加351.06%
康诺亚-B(02162.HK)将于8月27日举行董事会会议以审批中期业绩
格隆汇资讯 · 08-15
康诺亚-B(02162.HK)将于8月27日举行董事会会议以审批中期业绩
创新药概念普升 百济神州(06160)涨3.14% 机构指出海授权和重磅创新将是行业投资催化剂
金吾财讯 · 08-15
创新药概念普升 百济神州(06160)涨3.14% 机构指出海授权和重磅创新将是行业投资催化剂
“行进中国”调研行|探寻生物医药的“蜀乡密码”
人民网 · 08-15
“行进中国”调研行|探寻生物医药的“蜀乡密码”
康诺亚-B08月08日主力资金流入184万元 连续3日加仓
自选股智能写手 · 08-08
康诺亚-B08月08日主力资金流入184万元 连续3日加仓
“Newco模式”火了!嘉和、康诺亚、恒瑞之后,资本攒局创新药出海前景几何?
医药经济报 · 08-07
“Newco模式”火了!嘉和、康诺亚、恒瑞之后,资本攒局创新药出海前景几何?
康诺亚-B(02162)上涨5.15%,报31.65元/股
金融界 · 07-31
康诺亚-B(02162)上涨5.15%,报31.65元/股
康诺亚-B盘中异动 临近收盘股价大涨5.15%报31.650港元
自选股智能写手 · 07-31
康诺亚-B盘中异动 临近收盘股价大涨5.15%报31.650港元
康诺亚-B(02162)股价上升5.15%,现价港币$31.65
阿斯达克财经 · 07-31
康诺亚-B(02162)股价上升5.15%,现价港币$31.65
康诺亚-B:获 1.85 亿美元合作款项,涨 5.09%
和讯网 · 07-17
康诺亚-B:获 1.85 亿美元合作款项,涨 5.09%
康诺亚-B午后涨超5% 已与Belenos Biosciences订立许可协议
新浪港股 · 07-17
康诺亚-B午后涨超5% 已与Belenos Biosciences订立许可协议
【港股异动 | 康诺亚-B(02162.HK)现涨超6% 与Belenos签订独家授权协议 海外授权两款自免双抗】智通财经APP获悉,康诺亚-B(02162.
智通财经 · 07-17
【港股异动 | 康诺亚-B(02162.HK)现涨超6% 与Belenos签订独家授权协议 海外授权两款自免双抗】智通财经APP获悉,康诺亚-B(02162.
港股异动 | 康诺亚-B(02162)现涨超6% 与Belenos签订独家授权协议 海外授权两款自免双抗
智通财经 · 07-17
港股异动 | 康诺亚-B(02162)现涨超6% 与Belenos签订独家授权协议 海外授权两款自免双抗
康诺亚-B(02162)上涨5.25%,报33.1元/股
金融界 · 07-17
康诺亚-B(02162)上涨5.25%,报33.1元/股
康诺亚-B盘中异动 股价大涨5.09%报33.050港元
自选股智能写手 · 07-17
康诺亚-B盘中异动 股价大涨5.09%报33.050港元
康诺亚-B(02162)股价上升5.246%,现价港币$33.1
阿斯达克财经 · 07-17
康诺亚-B(02162)股价上升5.246%,现价港币$33.1
康诺亚-B07月15日遭主力抛售423万元 环比增加415.85%
自选股智能写手 · 07-15
康诺亚-B07月15日遭主力抛售423万元 环比增加415.85%
康诺亚-B(02162)股价下跌9.157%,现价港币$31.25
阿斯达克财经 · 07-15
康诺亚-B(02162)股价下跌9.157%,现价港币$31.25
公司概况
公司名称:
康诺亚-B
所属市场:
SEHK
上市日期:
--
主营业务:
Keymed Biosciences Inc是一家中国生物科技公司。该公司专注于自主发现及开发创新生物疗法以满足自体免疫及肿瘤治疗领域中未获满足的医疗需求。该公司已掌握内部药物发现及开发技术,其中包括构成其创新抗体发现平台及自有新型T细胞重定向(nTCE)双特异性抗体平台的技术。该公司还建立了涵盖生物药开发的关键功能的全面一体化平台。该公司主要产品包括CM310、CM326以及CMG901等。
发行价格:
--
{"stockData":{"symbol":"02162","market":"HK","secType":"STK","nameCN":"康诺亚-B","latestPrice":32.4,"timestamp":1724400507031,"preClose":33.1,"halted":0,"volume":237000,"delay":0,"floatShares":279735566,"shares":279735566,"eps":-1.5066628,"marketStatus":"休市中","marketStatusCode":7,"change":-0.7,"latestTime":"08-23 16:08:27","open":32.45,"high":32.95,"low":32.05,"amount":7667250,"amplitude":0.02719,"askPrice":32.45,"askSize":500,"bidPrice":32.35,"bidSize":5000,"shortable":3,"etf":0,"ttmEps":-1.5066628734709155,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1724635800000},"adr":0,"listingDate":1625673600000,"adjPreClose":33.1,"openAndCloseTimeList":[[1724376600000,1724385600000],[1724389200000,1724400000000]],"volumeRatio":0.5714197537501203,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02162/wiki","defaultTab":"wiki","newsList":[{"id":"2461816475","title":"康诺亚-B08月21日遭主力抛售105万元 环比增加288.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2461816475","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461816475?lang=zh_cn&edition=full","pubTime":"2024-08-21 16:15","pubTimestamp":1724228116,"startTime":"0","endTime":"0","summary":"08月21日, 康诺亚-B股价涨2.22%,报收32.30元,成交金额1260万元,换手率0.14%,振幅4.43%,量比1.07。康诺亚-B今日主力资金净流出105万元,连续4日净流出,上一交易日主力净流出27万元,今日环比增加288.89%。近一年数据显示,该股主力连续4日净流出后,次日下跌概率为50.00%,平均跌幅为5.00%。该股近5个交易日上涨1.25%,主力资金累计净流出390万元;近20日主力资金累计净流入408万元,其中净流入天数为5日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408211615279f41370b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408211615279f41370b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1161","02162","BK1587","BK1574"],"gpt_icon":0},{"id":"2460302939","title":"康诺亚-B08月20日主力资金流出27万元 连续3日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2460302939","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460302939?lang=zh_cn&edition=full","pubTime":"2024-08-20 16:15","pubTimestamp":1724141729,"startTime":"0","endTime":"0","summary":"08月20日, 康诺亚-B股价涨2.10%,报收31.60元,成交金额1394万元,换手率0.16%,振幅4.36%,量比1.04。康诺亚-B今日主力资金净流出27万元,连续3日净流出,上一交易日主力净流出212万元,今日环比减少87.26%。近一年数据显示,该股主力连续3日净流出后,次日下跌概率为58.33%,平均跌幅为3.97%。该股近5个交易日下跌4.98%,主力资金累计净流出346万元,其中1个交易日为股价上涨时净流出;近20日主力资金累计净流入292万元,其中净流入天数为5日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408201615449f3d0a45&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408201615449f3d0a45&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1587","02162","BK1574","BK1583","BK1161"],"gpt_icon":0},{"id":"2460702873","title":"康诺亚-B08月19日遭主力抛售212万元 环比增加351.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460702873","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460702873?lang=zh_cn&edition=full","pubTime":"2024-08-19 16:16","pubTimestamp":1724055364,"startTime":"0","endTime":"0","summary":"08月19日, 康诺亚-B股价跌2.83%,报收30.95元,成交金额1194万元,换手率0.14%,振幅5.81%,量比0.75。康诺亚-B今日主力资金净流出212万元,上一交易日主力净流出47万元,今日环比增加351.06%。该股近5个交易日下跌8.18%,主力资金累计净流出319万元;近20日主力资金累计净流入351万元,其中净流入天数为6日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081916164595a62687&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081916164595a62687&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02162","BK1587","BK1583","BK1161","BK1574"],"gpt_icon":0},{"id":"2459410587","title":"康诺亚-B(02162.HK)将于8月27日举行董事会会议以审批中期业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2459410587","media":"格隆汇资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459410587?lang=zh_cn&edition=full","pubTime":"2024-08-15 16:59","pubTimestamp":1723712396,"startTime":"0","endTime":"0","summary":"格隆汇8月16日丨康诺亚-B(02162.HK)公布,公司将于2024年8月27日举行董事会会议,藉以考虑及通过公司及其附属公司截至2024年6月30日止六个月的中期业绩,以及考虑派发中期股息(如有)。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408151700119f2d3e77&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408151700119f2d3e77&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","BK1587","BK1583","02162"],"gpt_icon":0},{"id":"2459464598","title":"创新药概念普升 百济神州(06160)涨3.14% 机构指出海授权和重磅创新将是行业投资催化剂","url":"https://stock-news.laohu8.com/highlight/detail?id=2459464598","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459464598?lang=zh_cn&edition=full","pubTime":"2024-08-15 10:58","pubTimestamp":1723690691,"startTime":"0","endTime":"0","summary":"国金证券表示,从已披露中报看,创新药企业整体业绩向好趋势明显,百济神州、和黄药业、信达生物等部分药企核心品种销售表现亮丽。上半年以来,创新药鼓励政策陆续落地,此时叠加业绩改善,同时考虑海外流动性变化趋势,该行认为创新药板块有望继续得到市场重视,出海授权和重磅创新将是最大的投资催化剂。","market":"sg","thumbnail":"https://static.szfiu.com/news/20200908/ZDU2M2ViYzhjNGM0OGI0Yjc0M2IyM2I2YWYxMTE5OTk0MjE4MDAxMQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20200908/ZDU2M2ViYzhjNGM0OGI0Yjc0M2IyM2I2YWYxMTE5OTk0MjE4MDAxMQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"1942341","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0348783233.USD","BK1141","BK4548","BK4504","06978","01521","BK4505","02162","BK4139","BK4535","IE00B5MMRT66.SGD","LU0588546209.SGD","09969","IE00BPRC5H50.USD","09995","BK1500","BK4585","BK1583","BK4588","LU0307460666.USD","BK1161","LU2328871848.SGD","LU0348784397.USD","BK1191","LU1969619763.USD","01801","LU2488822045.USD","06160","BK0239","BGNE","09926","BK1588","BK1574","IE00B543WZ88.USD","LU1720050803.USD","BK1576","BK1589","00013","688235","LU0417516571.SGD","159992","LU1794554557.SGD","BK1587","BK4526"],"gpt_icon":0},{"id":"2459245047","title":"“行进中国”调研行|探寻生物医药的“蜀乡密码”","url":"https://stock-news.laohu8.com/highlight/detail?id=2459245047","media":"人民网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459245047?lang=zh_cn&edition=full","pubTime":"2024-08-15 09:30","pubTimestamp":1723685438,"startTime":"0","endTime":"0","summary":"编者按在“行”中,看见“进”的中国。今年5月,人民网启动“行进中国”大型融媒体系列调研行,340名年轻记者,耗时2个月,走访31个省区市的111座城市,前往500余个基层一线点位深入采访,“即采即发”“边采边发”,推出融媒体作品600余件,各平台总阅读量超11亿。8月13日起,人民网分“创新中国”“品牌中国”“投资中国...","market":"us","thumbnail":"https://inews.gtimg.com/om_ls/Oh6jDhEAoeLHMvMZF5-uYdPCL90QY3a-9pz97vtU0GyKUAA_294195/0","type":0,"news_type":0,"thumbnails":["https://inews.gtimg.com/om_ls/Oh6jDhEAoeLHMvMZF5-uYdPCL90QY3a-9pz97vtU0GyKUAA_294195/0"],"rights":{"source":"tencent_tech","url":"https://new.qq.com/rain/a/20240815A01KW900","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.author, .pubtime{#sourceStyle#; display: inline-block;} .pubtime{margin-left: 3px;}strong{font-weight:500;#lv2TextColor#}","selectors":".main-wrapper","filters":".follow_top, .channel-entry, .collapseWrapper, .pic, .gap, .showDividingLine, .loader, .container, .ct-sumary, .nav, .landad, .hairline-top, .footer, .recommend-modules, .headroom-wrapper, .elevator","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://new.qq.com/rain/a/20240815A01KW900","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent_tech","symbols":["BK1161","02162","BK1583","BK1587","BK1574"],"gpt_icon":0},{"id":"2457365888","title":"康诺亚-B08月08日主力资金流入184万元 连续3日加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2457365888","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457365888?lang=zh_cn&edition=full","pubTime":"2024-08-08 16:17","pubTimestamp":1723105022,"startTime":"0","endTime":"0","summary":"08月08日, 康诺亚-B股价跌2.19%,报收33.45元,成交金额2409万元,换手率0.25%,振幅4.53%,量比0.85。康诺亚-B今日主力资金净流入184万元,连续3日净流入,上一交易日主力净流入925万元,今日环比减少80.11%。近一年数据显示,该股主力连续3日净流入后,次日上涨概率为62.50%,平均涨幅为2.45%。该股近5个交易日上涨3.42%,主力资金累计净流入1360万元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流出6万元,其中净流出天数为9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408081617519588339d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408081617519588339d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1161","02162","BK1587","BK1574"],"gpt_icon":0},{"id":"2457981811","title":"“Newco模式”火了!嘉和、康诺亚、恒瑞之后,资本攒局创新药出海前景几何?","url":"https://stock-news.laohu8.com/highlight/detail?id=2457981811","media":"医药经济报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457981811?lang=zh_cn&edition=full","pubTime":"2024-08-07 18:52","pubTimestamp":1723027959,"startTime":"0","endTime":"0","summary":"通过与海外资本合作成立新公司的“NewCo模式”出海,正成为本土创新药企实现国际化战略的一种新趋势。嘉和生物此次的交易,也让“NewCo模式”再次引发关注。据不完全统计,目前采取“NewCo模式”出海的本土企业至少有四家,主要是集中在今年交易。事实上,“NewCo模式”在海外跨国制药企业中不乏先例,但在国内确实是项较新的探索。“NewCo模式”引领风潮资本攒局出海前景几何?而国内“NewCo模式”的成功案例更早可以追溯到2021年。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408071913589585af16&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408071913589585af16&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02162","BK1161","06998","BK1574","BK1587","06978","600276","BK1583"],"gpt_icon":0},{"id":"2455977110","title":"康诺亚-B(02162)上涨5.15%,报31.65元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2455977110","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455977110?lang=zh_cn&edition=full","pubTime":"2024-07-31 15:40","pubTimestamp":1722411609,"startTime":"0","endTime":"0","summary":"7月31日,康诺亚-B(02162)盘中上涨5.15%,截至15:40,报31.65元/股,成交2598.06万元。康诺亚生物医药科技有限公司专注于研发高质量、可负担的创新疗法,主要业务包括分子发现、工艺开发、转化医学、临床开发到商业化生产药品开发全周期。公司自主研发的一类创新药逾30项,其中9项已进入不同阶段临床研发,多项位于中国第一,世界前三,包含一项世界首创ADC新药,两项获得国家“十三五”“重大新药创制”科技重大专项支持。截至2023年年报,康诺亚-B营业总收入3.54亿元、净利润-3.59亿元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/07/31154041927092.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1587","02162","BK1574","BK1583","BK1161"],"gpt_icon":0},{"id":"2455166903","title":"康诺亚-B盘中异动 临近收盘股价大涨5.15%报31.650港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2455166903","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455166903?lang=zh_cn&edition=full","pubTime":"2024-07-31 15:40","pubTimestamp":1722411602,"startTime":"0","endTime":"0","summary":"2024年07月31日临近收盘15时40分,康诺亚-B股票出现异动,股价大幅上涨5.15%。截至发稿,该股报31.650港元/股,成交量83.6万股,换手率0.30%,振幅6.81%。资金方面,该股资金流入1637.07万港元,流出611.525万港元。康诺亚-B股票所在的生物技术行业中,整体涨幅为2.30%。其相关个股中,科笛-B、药明合联、来凯医药-B涨幅较大,振幅较大的相关个股有科笛-B、华康生物医学、药明合联,振幅分别为30.77%、27.46%、18.86%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240731154003aefc64b9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240731154003aefc64b9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02162","BK1587","BK1161","BK1583","BK1574"],"gpt_icon":0},{"id":"2455862970","title":"康诺亚-B(02162)股价上升5.15%,现价港币$31.65","url":"https://stock-news.laohu8.com/highlight/detail?id=2455862970","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455862970?lang=zh_cn&edition=full","pubTime":"2024-07-31 15:40","pubTimestamp":1722411600,"startTime":"0","endTime":"0","summary":"[上升股]康诺亚-B(02162) 股价在下午03:40比前收市价上升5.15%,现股价为港币$31.65。至目前为止,今日最高价为$31.65,而最低价为$29.6。总成交量为83.4万股,总成交金额为港币$2.592千万。","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20190212132919673_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20190212132919673_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2407316544/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1574","BK1583","BK1161","BK1587","02162"],"gpt_icon":0},{"id":"2452449907","title":"康诺亚-B:获 1.85 亿美元合作款项,涨 5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452449907","media":"和讯网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452449907?lang=zh_cn&edition=full","pubTime":"2024-07-17 13:33","pubTimestamp":1721194425,"startTime":"0","endTime":"0","summary":"【康诺亚-B午后上涨 5.09%,现报 33.05 港元,成交额 1902.73 万港元】7 月 9 日,康诺亚宣布与 Belenos Biosciences 订立许可协议,授予后者全球研究、开发、注册、生产及商业化 CM512 及 CM536 两款双抗的独家权利。作为对价,康诺亚将收取 1500 万美元的首付款和近期付款,其全资附属公司一桥香港将收取 Belenos 约 30.01%的股权。此外,根据项目的开发、监管及商业里程碑达成情况,康诺亚有望获得最多 1.70 亿美元的额外付款。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407171351549f5b5629&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407171351549f5b5629&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","BK1587","BK1583","02162"],"gpt_icon":0},{"id":"2452901051","title":"康诺亚-B午后涨超5% 已与Belenos Biosciences订立许可协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2452901051","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452901051?lang=zh_cn&edition=full","pubTime":"2024-07-17 13:13","pubTimestamp":1721193211,"startTime":"0","endTime":"0","summary":"康诺亚-B(02162)午后上涨5.09%,现报33.05港元,成交额1902.73万港元。\n 7月9日,康诺亚宣布已与Belenos Biosciences订立许可协议,授予后者在全球(不包括大中华地区)研究、开发、注册、生产及商业化CM512及CM536两款双抗的独家权利。\n 据悉,作为对价,康诺亚将收取1500万美元的首付款和近期付款,而其全资附属公司一桥香港将收取Belenos约30.01%的股权;此外,根据项目的开发、监管及商业里程碑达成情况,康诺亚亦有望获得最多1.70亿美元的额外付款。\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"highlight_sina","url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-07-17/doc-incemisy0475878.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}","selectors":".art_box, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action, .fl_popup, .weibo_info","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-07-17/doc-incemisy0475878.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_sina","symbols":["BK1574","BK1583","BK1587","02162","BK1161"],"gpt_icon":0},{"id":"2452960905","title":"【港股异动 | 康诺亚-B(02162.HK)现涨超6% 与Belenos签订独家授权协议 海外授权两款自免双抗】智通财经APP获悉,康诺亚-B(02162.","url":"https://stock-news.laohu8.com/highlight/detail?id=2452960905","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452960905?lang=zh_cn&edition=full","pubTime":"2024-07-17 11:57","pubTimestamp":1721188678,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1587","YANG","02162","HSTECH","BK1161","BK1574","BK1583","07226","HSCEI"],"gpt_icon":0},{"id":"2452948905","title":"港股异动 | 康诺亚-B(02162)现涨超6% 与Belenos签订独家授权协议 海外授权两款自免双抗","url":"https://stock-news.laohu8.com/highlight/detail?id=2452948905","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452948905?lang=zh_cn&edition=full","pubTime":"2024-07-17 11:57","pubTimestamp":1721188678,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,康诺亚-B(02162)现涨超6%,截止发稿,涨5.88%,报33.3港元,成交额1703.8万港元。消息面上,7月9日,康诺亚宣布已与Belenos Biosciences订立许可协议,授予后者在全球(不包括大中华地区)研究、开发、注册、生产及商业化CM512及CM536两款双抗的独家权利。据悉,作为对价,康诺亚将收取1500万美元的首付款和近期付款,而其全资附属公司一桥香港将收取Belenos约30.01%的股权;此外,根据项目的开发、监管及商业里程碑达成情况,康诺亚亦有望获得最多1.70亿美元的额外付款。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1151922.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1587","YANG","02162","HSTECH","BK1161","BK1574","BK1583","07226","HSCEI"],"gpt_icon":0},{"id":"2452903826","title":"康诺亚-B(02162)上涨5.25%,报33.1元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2452903826","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452903826?lang=zh_cn&edition=full","pubTime":"2024-07-17 11:25","pubTimestamp":1721186745,"startTime":"0","endTime":"0","summary":"7月17日,康诺亚-B(02162)盘中上涨5.25%,截至11:25,报33.1元/股,成交1451.2万元。康诺亚生物医药科技有限公司专注于研发高质量、可负担的创新疗法,主要业务包括分子发现、工艺开发、转化医学、临床开发到商业化生产药品开发全周期。公司自主研发的一类创新药逾30项,其中9项已进入不同阶段临床研发,多项位于中国第一,世界前三,包含一项世界首创ADC新药,两项获得国家“十三五”“重大新药创制”科技重大专项支持。截至2023年年报,康诺亚-B营业总收入3.54亿元、净利润-3.59亿元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/07/17112541613484.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1587","02162","BK1574","BK1583","BK1161"],"gpt_icon":0},{"id":"2452903874","title":"康诺亚-B盘中异动 股价大涨5.09%报33.050港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452903874","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452903874?lang=zh_cn&edition=full","pubTime":"2024-07-17 11:25","pubTimestamp":1721186744,"startTime":"0","endTime":"0","summary":"2024年07月17日早盘11时25分,康诺亚-B股票出现波动,股价快速拉升5.09%。截至发稿,该股报33.050港元/股,成交量44.7万股,换手率0.16%,振幅4.93%。资金方面,该股资金流入809.145万港元,流出491.615万港元。康诺亚-B股票所在的生物技术行业中,整体涨幅为1.10%。其相关个股中,百奥赛图-B、泰格医药、永泰生物-B涨幅较大,振幅较大的相关个股有盛禾生物-B、百奥赛图-B、维亚生物,振幅分别为16.10%、9.30%、7.69%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717112544941f7b46&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717112544941f7b46&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02162","BK1587","BK1583","BK1161","BK1574"],"gpt_icon":0},{"id":"2452456903","title":"康诺亚-B(02162)股价上升5.246%,现价港币$33.1","url":"https://stock-news.laohu8.com/highlight/detail?id=2452456903","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452456903?lang=zh_cn&edition=full","pubTime":"2024-07-17 11:25","pubTimestamp":1721186700,"startTime":"0","endTime":"0","summary":"[上升股]康诺亚-B(02162) 股价在上午11:25比前收市价上升5.246%,现股价为港币$33.1。至目前为止,今日最高价为$33.1,而最低价为$31.45。总成交量为44.75万股,总成交金额为港币$1.453千万。","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180126133719348_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180126133719348_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR240717865/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02162","BK1161","BK1574","BK1587","BK1583"],"gpt_icon":0},{"id":"2451235613","title":"康诺亚-B07月15日遭主力抛售423万元 环比增加415.85%","url":"https://stock-news.laohu8.com/highlight/detail?id=2451235613","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2451235613?lang=zh_cn&edition=full","pubTime":"2024-07-15 16:15","pubTimestamp":1721031340,"startTime":"0","endTime":"0","summary":"07月15日, 康诺亚-B股价跌8.14%,报收31.60元,成交金额6202万元,换手率0.70%,振幅9.45%,量比2.21。康诺亚-B今日主力资金净流出423万元,上一交易日主力净流出82万元,今日环比增加415.85%。该股近5个交易日上涨1.27%,主力资金累计净流出339万元;近20日主力资金累计净流出423万元,其中净流出天数为8日。该股主力净额占比0.05%,港股市场排名2580/2648。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071516160595bf2a2a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071516160595bf2a2a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02162","BK1583","BK1587","BK1574"],"gpt_icon":0},{"id":"2451699139","title":"康诺亚-B(02162)股价下跌9.157%,现价港币$31.25","url":"https://stock-news.laohu8.com/highlight/detail?id=2451699139","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2451699139?lang=zh_cn&edition=full","pubTime":"2024-07-15 14:28","pubTimestamp":1721024880,"startTime":"0","endTime":"0","summary":"[下跌股]康诺亚-B(02162) 股价在下午02:28比前收市价下跌9.157%,现股价为港币$31.25。至目前为止,今日最高价为$34.3,而最低价为$31.25。总成交量为145.05万股,总成交金额为港币$4.653千万。","market":"sh","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180725131625844_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180725131625844_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2407151452/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1574","BK1583","BK1587","02162","BK1161"],"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0.0173},{"period":"1month","weight":0.0468},{"period":"3month","weight":-0.0512},{"period":"6month","weight":-0.0107},{"period":"1year","weight":-0.3361},{"period":"ytd","weight":-0.3401}],"compareEarnings":[{"period":"1week","weight":0.0104},{"period":"1month","weight":0.0174},{"period":"3month","weight":-0.0536},{"period":"6month","weight":0.053},{"period":"1year","weight":-0.0329},{"period":"ytd","weight":0.0331}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"Keymed Biosciences Inc是一家中国生物科技公司。该公司专注于自主发现及开发创新生物疗法以满足自体免疫及肿瘤治疗领域中未获满足的医疗需求。该公司已掌握内部药物发现及开发技术,其中包括构成其创新抗体发现平台及自有新型T细胞重定向(nTCE)双特异性抗体平台的技术。该公司还建立了涵盖生物药开发的关键功能的全面一体化平台。该公司主要产品包括CM310、CM326以及CMG901等。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.102216},{"month":2,"riseRate":0.666667,"avgChangeRate":0.052845},{"month":3,"riseRate":0,"avgChangeRate":-0.111304},{"month":4,"riseRate":1,"avgChangeRate":0.048679},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.125967},{"month":6,"riseRate":1,"avgChangeRate":0.150041},{"month":7,"riseRate":0.333333,"avgChangeRate":0.066538},{"month":8,"riseRate":0.5,"avgChangeRate":-0.006665},{"month":9,"riseRate":0.666667,"avgChangeRate":-0.014017},{"month":10,"riseRate":0.666667,"avgChangeRate":0.069277},{"month":11,"riseRate":0.666667,"avgChangeRate":0.090203},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.129089}],"exchange":"SEHK","name":"康诺亚-B","nameEN":"KEYMED BIO-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"康诺亚-B(02162)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供康诺亚-B(02162)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"康诺亚-B,02162,康诺亚-B股票,康诺亚-B股票老虎,康诺亚-B股票老虎国际,康诺亚-B行情,康诺亚-B股票行情,康诺亚-B股价,康诺亚-B股市,康诺亚-B股票价格,康诺亚-B股票交易,康诺亚-B股票购买,康诺亚-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"康诺亚-B(02162)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供康诺亚-B(02162)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}